These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 10938386

  • 21. Alterations of transforming growth factor beta receptor II, insulin growth factor receptor II genes in microsatellite unstable prostate carcinomas.
    Bhattacharyya N, Tao J, Klein EA, Banerjee S.
    Oncol Rep; 2004 Jan; 11(1):231-6. PubMed ID: 14654931
    [Abstract] [Full Text] [Related]

  • 22. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.
    Periyasamy S, Ammanamanchi S, Tillekeratne MP, Brattain MG.
    Oncogene; 2000 Sep 21; 19(40):4660-7. PubMed ID: 11030155
    [Abstract] [Full Text] [Related]

  • 23. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
    Ko Y, Banerji SS, Liu Y, Li W, Liang J, Soule HD, Pauley RJ, Willson JK, Zborowska E, Brattain MG.
    J Cell Physiol; 1998 Aug 21; 176(2):424-34. PubMed ID: 9648930
    [Abstract] [Full Text] [Related]

  • 24. Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells.
    Yang HK, Kang SH, Kim YS, Won K, Bang YJ, Kim SJ.
    Oncogene; 1999 Apr 01; 18(13):2213-9. PubMed ID: 10327067
    [Abstract] [Full Text] [Related]

  • 25. Mutation analysis of the transforming growth factor beta type II receptor in sporadic human cancers of the pancreas, liver, and breast.
    Vincent F, Hagiwara K, Ke Y, Stoner GD, Demetrick DJ, Bennett WP.
    Biochem Biophys Res Commun; 1996 Jun 25; 223(3):561-4. PubMed ID: 8687435
    [Abstract] [Full Text] [Related]

  • 26. TbetaR-I(6A) is a candidate tumor susceptibility allele.
    Pasche B, Kolachana P, Nafa K, Satagopan J, Chen YG, Lo RS, Brener D, Yang D, Kirstein L, Oddoux C, Ostrer H, Vineis P, Varesco L, Jhanwar S, Luzzatto L, Massagué J, Offit K.
    Cancer Res; 1999 Nov 15; 59(22):5678-82. PubMed ID: 10582683
    [Abstract] [Full Text] [Related]

  • 27. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.
    Cancer Res; 2004 Aug 01; 64(15):5200-11. PubMed ID: 15289325
    [Abstract] [Full Text] [Related]

  • 28. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
    Deacu E, Mori Y, Sato F, Yin J, Olaru A, Sterian A, Xu Y, Wang S, Schulmann K, Berki A, Kan T, Abraham JM, Meltzer SJ.
    Cancer Res; 2004 Nov 01; 64(21):7690-6. PubMed ID: 15520171
    [Abstract] [Full Text] [Related]

  • 29. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.
    Grady WM, Myeroff LL, Swinler SE, Rajput A, Thiagalingam S, Lutterbaugh JD, Neumann A, Brattain MG, Chang J, Kim SJ, Kinzler KW, Vogelstein B, Willson JK, Markowitz S.
    Cancer Res; 1999 Jan 15; 59(2):320-4. PubMed ID: 9927040
    [Abstract] [Full Text] [Related]

  • 30. Functional characterization of transforming growth factor beta type II receptor mutants in human cancer.
    De M, Yan W, de Jonge RR, Garrigue-Antar L, Vellucci VF, Reiss M.
    Cancer Res; 1998 May 01; 58(9):1986-92. PubMed ID: 9581843
    [Abstract] [Full Text] [Related]

  • 31. Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer.
    Chen T, Carter D, Garrigue-Antar L, Reiss M.
    Cancer Res; 1998 Nov 01; 58(21):4805-10. PubMed ID: 9809982
    [Abstract] [Full Text] [Related]

  • 32. Mutations of the transforming growth factor beta type II receptor gene and microsatellite instability in gastric cancer.
    Ohue M, Tomita N, Monden T, Miyoshi Y, Ohnishi T, Izawa H, Kawabata Y, Sasaki M, Sekimoto M, Nishisho I, Shiozaki H, Monden M.
    Int J Cancer; 1996 Oct 09; 68(2):203-6. PubMed ID: 8900429
    [Abstract] [Full Text] [Related]

  • 33. MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells.
    Lee BI, Park SH, Kim JW, Sausville EA, Kim HT, Nakanishi O, Trepel JB, Kim SJ.
    Cancer Res; 2001 Feb 01; 61(3):931-4. PubMed ID: 11221885
    [Abstract] [Full Text] [Related]

  • 34. Human cut-like repressor protein binds TGFbeta type II receptor gene promoter.
    Jackson RJ, Antonia SJ, Wright KL, Moon NS, Nepveu A, Muñoz-Antonia T.
    Arch Biochem Biophys; 1999 Nov 15; 371(2):290-300. PubMed ID: 10545217
    [Abstract] [Full Text] [Related]

  • 35. RRR-alpha-tocopheryl succinate enhances TGF-beta 1, -beta 2, and -beta 3 and TGF-beta R-II expression by human MDA-MB-435 breast cancer cells.
    Charpentier A, Simmons-Menchaca M, Yu W, Zhao B, Qian M, Heim K, Sanders BG, Kline K.
    Nutr Cancer; 1996 Nov 15; 26(2):237-50. PubMed ID: 8875561
    [Abstract] [Full Text] [Related]

  • 36. Expression of transforming growth factor beta1 and its type II receptor in mouse colon tumors induced by azoxymethane.
    Wang QS, Guda K, Papanikolaou A, Dong M, Rosenberg DW.
    Int J Oncol; 2000 Sep 15; 17(3):551-8. PubMed ID: 10938397
    [Abstract] [Full Text] [Related]

  • 37. Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line.
    Yamamoto N, Imai J, Watanabe M, Hiroi N, Sugano S, Yoshino G.
    Horm Metab Res; 2006 Mar 15; 38(3):159-66. PubMed ID: 16673206
    [Abstract] [Full Text] [Related]

  • 38. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS, Lee HS, Kim TY, Im YH, Park JW, Kim NK, Bang YJ.
    Biochem Biophys Res Commun; 2002 Mar 29; 292(2):383-9. PubMed ID: 11906173
    [Abstract] [Full Text] [Related]

  • 39. Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related transcription factor, induces endogenous TGF-beta type II receptor expression and restores the TGF-beta signaling pathway in Hs578t human breast cancer cells.
    Chang J, Lee C, Hahm KB, Yi Y, Choi SG, Kim SJ.
    Oncogene; 2000 Jan 06; 19(1):151-4. PubMed ID: 10644990
    [Abstract] [Full Text] [Related]

  • 40. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D, Kanuma T, Mizunuma H, Takama F, Ibuki Y, Wake N, Mogi A, Shitara Y, Takenoshita S.
    Cancer Res; 2000 Aug 15; 60(16):4507-12. PubMed ID: 10969799
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.